1. Home
  2. CALX vs EVO Comparison

CALX vs EVO Comparison

Compare CALX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALX
  • EVO
  • Stock Information
  • Founded
  • CALX 1999
  • EVO 1993
  • Country
  • CALX United States
  • EVO Germany
  • Employees
  • CALX N/A
  • EVO N/A
  • Industry
  • CALX Telecommunications Equipment
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CALX Consumer Discretionary
  • EVO Health Care
  • Exchange
  • CALX Nasdaq
  • EVO Nasdaq
  • Market Cap
  • CALX 2.9B
  • EVO 1.5B
  • IPO Year
  • CALX 2010
  • EVO 2021
  • Fundamental
  • Price
  • CALX $52.03
  • EVO $4.21
  • Analyst Decision
  • CALX Strong Buy
  • EVO Buy
  • Analyst Count
  • CALX 5
  • EVO 2
  • Target Price
  • CALX $48.20
  • EVO $5.90
  • AVG Volume (30 Days)
  • CALX 550.7K
  • EVO 112.1K
  • Earning Date
  • CALX 07-21-2025
  • EVO 08-13-2025
  • Dividend Yield
  • CALX N/A
  • EVO N/A
  • EPS Growth
  • CALX N/A
  • EVO N/A
  • EPS
  • CALX N/A
  • EVO N/A
  • Revenue
  • CALX $825,450,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • CALX $10.66
  • EVO $10.08
  • Revenue Next Year
  • CALX $9.99
  • EVO $10.99
  • P/E Ratio
  • CALX N/A
  • EVO N/A
  • Revenue Growth
  • CALX N/A
  • EVO 1.50
  • 52 Week Low
  • CALX $28.61
  • EVO $2.84
  • 52 Week High
  • CALX $53.66
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • CALX 79.16
  • EVO 54.31
  • Support Level
  • CALX $46.14
  • EVO $3.73
  • Resistance Level
  • CALX $48.88
  • EVO $4.29
  • Average True Range (ATR)
  • CALX 0.93
  • EVO 0.11
  • MACD
  • CALX 0.19
  • EVO 0.01
  • Stochastic Oscillator
  • CALX 98.74
  • EVO 67.61

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: